H. Mulcahy

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Hughe. Mulcahy, Hugh E. Mulcahy, H.e Mulcahy, H. E. Mulcahy, H E Mulcahy, H. Mulcahy, Hugh E Mulcahy, H Mulcahy, Hugh Mulcahy
Publication record
287 papers · 6,688 citations · H-index 42

PAPERS

Tu1790 COMBINATION BIOLOGIC OR SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE
20230 citationsauthor #22
Su1123 IMPACT OF MICRONUTRIENT DEFICIENCY IN AN INFLAMMATORY BOWEL DISEASE COHORT ON RESPONSE TO COVID-19 BOOSTER VACCINATION
20230 citationsauthor #10
Tu1771 THE USE OF BIOLOGICS HAS ALTERED THE DISEASE PHENOTYPE OBSERVED IN SURGICAL RESECTIONS FOR CROHN'S DISEASE: TRENDS IN ILEOCAECAL HISTOPATHOLOGY SINCE THE INTRODUCTION OF BIOLOGICS
20230 citationsauthor #9
Reduced serological response to COVID-19 booster vaccine is associated with reduced B cell memory in patients with Inflammatory Bowel Disease; VARIATION (VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON).
20235 citationsauthor #13
Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
202220 citationsauthor #12
Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
20220 citationsauthor #10
Sa1577: TRENDS IN COLECTOMY RATES AND BIOLOGIC USE OVER A 30-YEAR PERIOD: WHAT HAS CHANGED? A SINGLE CENTRE PERSPECTIVE
20220 citationsauthor #8
Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program
20218 citationsauthor #6
A case–control study examining the association of smad7 and TLR single nucleotide polymorphisms on the risk of colorectal cancer in ulcerative colitis
202112 citationsauthor #8
The Impact Of Sars-Cov-2 On The Irish National Colorectal Cancer Screening Programme: A Report From Two High-Volume Endoscopy Centres
20211 citationsauthor #11
The effect of sedation on EGD inspection time.
20211 citationsauthor #4
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease
20202 citationsauthor #15
Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme
20201 citationsauthor #11
Su1867 – Sustainanility of Biologic Therapies is Less in Ulcerative Colitis that Crohns Disease Patients Independent of Prior Biologic Experience
20190 citationsauthor #7
251 – Endoscopist-Related Factors Influencing Polyp Detection Rate in a National Colorectal Cancer Screening Programme
20190 citationsauthor #6
Prospective cohort study of appendicectomy for treatment of therapy‐refractory ulcerative colitis
201939 citationsauthor #8
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.
2019151 citationsauthor #12
Su1668 – The Correlation of Fit Levels with Pathological Results in a National Colorectal Cancer Screening Programme
20190 citationsauthor #6
Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
20198 citationsauthor #4
P405 Sustainability of biologic therapies is less in UC than CD patients independent of prior biologic experience
20190 citationsauthor #7
DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in Ulcerative Colitis.
201922 citationsauthor #3
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction
201912 citationsauthor #14
P470 DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
20190 citationsauthor #3
P401 Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease
20190 citationsauthor #14
Mo1640 - Perceptions and Beliefs of Invitees to Round 1 of the Irish National Colorectal Cancer Screening Programme
20180 citationsauthor #5
Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation.
201856 citationsauthor #3
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence
201815 citationsauthor #5
DOP077 Deep immunophenotyping reveals a role for Mucosal Associated Invariant T (MAIT) cells in the response to anti-TNF treatment in Crohn’s disease
20180 citationsauthor #6
Patient Education in Inflammatory Bowel Disease: A Patient-Centred, Mixed Methodology Study
201834 citationsauthor #12
P329 Utility of faecal calprotectin to assess Crohn’s disease activity in patients with an ileostomy
20181 citationsauthor #5
675 - Therapy Refractory Ulcerative Colitis Patients may Benefit from Appendectomy; Long-Term Clinical Results from a Multicenter Prospective Cohort Series
20180 citationsauthor #4
P597 Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure
20182 citationsauthor #15
P481 Induction treatment with subcutaneous rather than intravenous ustekinumab is associated with comparable circulating drugs levels and early clinical response
20180 citationsauthor #3
Sa1794 - Utility of Faecal Calprotectin to Assess Crohn's Disease Activity in Patients with an Ileostomy
20180 citationsauthor #5
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis
201810 citationsauthor #18
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study
201819 citationsauthor #5
P452 Medium to long-term outcomes in patients receiving accelerated dose infliximab induction for acute severe ulcerative colitis (ASUC) in a multi-centre cohort
20183 citationsauthor #8
Mo1868 - Medium to Long Term Outcomes in Patients Receiving Accelerated Dose Infliximab Induction for Acute Severe Ulcerative Colitis (ASUC) in a Mulit-Centre Cohort
20181 citationsauthor #8
Mo1849 - Induction Treatment with Subcutaneous Rather than Intravenous Ustekinumab is Associated with Comparable Circulating Drug Levels and Early Clinical Response
20181 citationsauthor #3
P582 Vedolizumab: Effects on liver function in an IBD and IBD/PSC cohort
20182 citationsauthor #5
Tu1819 - Deep Immunophenotyping Reveals a Role for Mucosal Associated Invariant T (MAIT) Cells in the Response to Antitnf Treatment in Crohn's Disease
20180 citationsauthor #6
Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
201810 citationsauthor #12
P578 Therapy refractory ulcerative colitis patients may benefit from appendectomy: long-term clinical results from a multicentre prospective cohort series
20183 citationsauthor #4
P370 A randomised controlled trial of acceptance and commitment therapy for the treatment of stress in inflammatory bowel disease.
20173 citationsauthor #1
P250 DUBLIN (Degree of Ulcerative Colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis.
20173 citationsauthor #5
Dublin (Degree of Ulcerative Colitis Burden of Luminal Inflammation) Score, a Simple Method to Quantify Inflammatory Burden in Ulcerative Colitis
20175 citationsauthor #5
A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening population
20177 citationsauthor #9
CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis
201780 citationsauthor #11
A Randomised Controlled Trial of Acceptance and Commitment Therapy (ACT) for the Treatment of Stress in Inflammatory Bowel Disease
20175 citationsauthor #8
Covered self-expanding metal stents for the management of common bile duct stones.
201738 citationsauthor #7
A National Study of Cancer Diagnoses in Irish Liver Transplant Recipients with Primary Sclerosing Cholangitis
20170 citationsauthor #8
Can MRE be Used as an Alternative to Rutgeerts' Score at Ileocolonoscopy for Grading Post-Operative Recurrence in Crohn's Disease?
20170 citationsauthor #5
DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis.
2016113 citationsauthor #17
Su1049 FIT-Positive Colorectal Cancer (CRC) Screening Colonoscopy: High Sensitivity or Just Serendipity?
20160 citationsauthor #7
Sa1913 Changes in Medical Treatment and Surgical Rates in Inflammatory Bowel Disease: A Single Centre Irish Cohort Study 1990-2015
20160 citationsauthor #7
Sa1062 What is the Effect of IBD on Sedation rates at Colonoscopy
20160 citationsauthor #5
Su1813 CRP/Albumin Ratio: A Novel Predictor of Early Colectomy in Acute Severe Ulcerative Colitis
20163 citationsauthor #10
992 Therapy Refractory Ulcerative Colitis Patients May Benefit From Appendectomy; Early Result From the Passion Study
20160 citationsauthor #11
Sa1761 Anti-TNF Therapy Switches on CD39+ FoxP3 Tregs in Association With Symptomatic and Endoscopic Remission in IBD
20150 citationsauthor #8
Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease
201546 citationsauthor #10
The Stressometer: A Simple, Valid, and Responsive Measure of Psychological Stress in Inflammatory Bowel Disease Patients.
201519 citationsauthor #6
Body Image Dissatisfaction: Clinical Features, and Psychosocial Disability in Inflammatory Bowel Disease
201587 citationsauthor #9
Sa1193 Ulcerative Proctitis: Predictors and Outcomes of Disease Extension in UC
20151 citationsauthor #4
Sa1239 Does Failure to Respond to One Anti-TNF Agent in Ulcerative Colitis Predict Treatment Failure With Other Anti-TNF Agents
20150 citationsauthor #4
Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
2015249 citationsauthor #7
Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn’s disease
201513 citationsauthor #7
Su1609 Fully Covered Metal Stents Facilitate Treatment of Complex Biliary Stone Disease
20150 citationsauthor #3
An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis.
2015251 citationsauthor #7
Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy
201550 citationsauthor #6
Su1282 Magnetic Resonance Enterography (MRE) Findings As Predictors of Clinical Outcome Following Anti-TNF Treatment in Crohn's Disease
20140 citationsauthor #6
323 Chemotherapy Induced Diarrhea in Colorectal Cancer: A Retrospective Analysis of Clinico-Pathological and Radiological Features
20140 citationsauthor #6
Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population
201458 citationsauthor #7
207 Accelerated Infliximab Rescue Reduces Early Colectomy Rate in Acute Severe Colitis
20141 citationsauthor #5
Determinants of short- and long-term survival from colorectal cancer in very elderly patients.
201417 citationsauthor #14
Mortality in inflammatory bowel disease patients under 65 years of age
20148 citationsauthor #7
N001 Development of a simple stressometer to assess stress in inflammatory bowel disease patients
20140 citationsauthor #5
DOP084 An accelerated infliximab dosing strategy for rescue therapy in acute severe colitis is associated with reduced early colectomy rate
20141 citationsauthor #6
The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease
201448 citationsauthor #9
Su1405 The Safety of Biologic Use in the Pregnant IBD Patient: Analysis of Patient Characteristics, Pregnancy and Neonatal Outcomes
20141 citationsauthor #7
Magnetic resonance colonography for assessment of acute severe colitis in pregnancy
20142 citationsauthor #4
DOP017 Dysbiosis in ulcerative colitis: adding the spatial component
20140 citationsauthor #11
Mo1910 Visceral Adiposity Is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy
20141 citationsauthor #6
Tu1775 Spatial Mapping of the Microbiota in Ulcerative Colitis
20140 citationsauthor #5
P652 Global DNA methylation in inflammatory bowel disease
20140 citationsauthor #7
Mo1369 Mortality in Inflammatory Bowel Disease Patients Under 65 Years of Age
20130 citationsauthor #7
AWARENESS OF ADVERSE EFFECTS OF AZATHIOPRINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
20130 citationsauthor #5
ON002 Simple question, simple answer, complex implications: What does a distress thermometer tell us about disease activity and quality of life in IBD patients?
20131 citationsauthor #7
PATIENTS WITH INTESTINAL INFLAMMATION REQUIRE MORE SEDATION DURING COLONOSCOPY
20132 citationsauthor #6
PREVALENCE OF DIFFERENT POLYP TYPES IN MSI AND MSS AGE AND GENDER MATCHED COHORTS OF COLORECTAL CANCER RESECTIONS
20130 citationsauthor #9
Mo1307 Time to First Surgery in Inflammatory Bowel Disease; His Bowel, Her Bowel
20130 citationsauthor #6
Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis.
201357 citationsauthor #5
The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients.
201338 citationsauthor #5
P208 Is availability of MR Enterography reducing avoidable use of ionising radiation in diagnostic imaging for Crohn's Disease?
20130 citationsauthor #6
Tu1351 Patients With Intestinal Inflammation Require More Sedation During Colonoscopy
20130 citationsauthor #6
OPTIMISING SCREENING FOR OPPORTUNISTIC INFECTION PRIOR TO ANTI-TNF THERAPY
20130 citationsauthor #5
Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn's disease.
201342 citationsauthor #7
P179 Premature mortality and inflammatory bowel disease
20130 citationsauthor #7
P127 Towards a patient reported Crohn's Disease Activity Index
20130 citationsauthor #8
Effects of Radiation on Levels of DNA Damage in Normal Non-adjacent Mucosa from Colorectal Cancer Cases
201310 citationsauthor #7
P587 Assessing how IBD patients see themselves? Validation and first use of a targeted body image instrument
20130 citationsauthor #8

TIMELINE

1991 0 citations

1992 5 citations

1993 41 citations

1994 559 citations

1995 22 citations

1996 251 citations

1997 415 citations

1998 88 citations

1999 26 citations

2000 159 citations

2001 31 citations

2002 298 citations

2003 394 citations

2004 543 citations

2005 817 citations

2006 46 citations

2007 56 citations

2008 19 citations

2009 534 citations

2010 18 citations

2011 421 citations

2012 152 citations

2013 243 citations

2014 137 citations

2015 716 citations

2016 116 citations

2017 141 citations

2018 157 citations

2019 232 citations

2020 3 citations

2021 22 citations

2022 20 citations

2023 5 citations

H. Mulcahy

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT